The approval marks a significant milestone for the American pharmaceutical company in the field of UC
The company plans to add 1700 beds by FY27 through the organic route
Executes the first project for developing and manufacturing a novel anticancer mAb
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The facility will manufacture tablets, capsules, and injections for the oncology segment
Operations of Line II was stopped due to a fire incident earlier
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
Hepatitis B infects over 40 million people in India
Subscribe To Our Newsletter & Stay Updated
